Breast cancer patients treated with alpelisib have elevated rates of high blood sugar
New research has uncovered elevated rates of high blood sugar, or hyperglycemia, among patients with breast cancer who are treated with the oral medication alpelisib. The results are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. Alpelisib targets the phosphoinositide 3-kinase (PI3K) protein that is involved in cell growth and when … Read more